1、Feng Xu , Rui Yang , Lingyun Wu et al. . Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome. . Cancer Letters,2012;317: 33–40
2、Xu Feng AND Li Xiao. The role of Histone methyltransferase EZH2 in myelodysplastic syndromes. Expert Rev.Hematol.,2012; 5(2):177-185
3、Li Xiao#,Zhu Qi, Chen Qiusheng et al. . The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression. Am J Hematol.,2012;87(1):26-31.
4、Yang Y, Zhang Q, Xu F,et al. . Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome. J Cancerres Clin Oncol,2012;138(5): 729-37
5、Xu Feng, Wu lingyun, He Qi et al. . Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.. Internal Medicine Journal,2012;42(4): 401-411
6、Xu F, Li X#, Wu L, Zhang Q, et al. . Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.. Ann Hematol,2011;90:643–653
7、Zhang Zheng, Xu Feng, Li Xiao#, et al. . Removal of autologous activated CD4-positive T lymphocytes also results in increased colony-forming units in patients with low and intermediate-1 risk myelodysplastic syndromes.. Eur J Haematol,2011;86(1)47-56
8、Lingyun Wu, Xiao Li#, Jiying Su, et al.. Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS . J Cancer Res Clin Oncol,2011;137:1563–1569
9、He Q, Li X#, Zhang Z,, et al.. Overexpression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes. . Cancer Invest,2010;28（10）:983-988
10、Xu F, Li X#, Wu L, et al. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes.. Br J Haematol.,2010;149 (4):587-97
11、Li Xiao#,Liao Qiong,Zhang yan et al.. Experimental and clinical characteristics in myelodysplastic syndrome patients with or without HLA-DRI5 allele. . Hematol Oncol,2010;28:98-103
12、Xiao Li#, Feng Xu, Qi He, et al.. Comparison of Immunological Abnormalities of Lymphocytes in Bone Marrow in Myelodysplastic Syndrome (MDS) and Aplastic Anemia (AA). Inter Med,2010;49:1349-1355
13、Zhang Zheng, Zhang Qianqiao, He Qi,et al. #. In vitro deprivation of CD8CD57 T cells promotes the malignant growth of bone marrow colony cells in patients with ower-risk myelodysplastic syndrome. Experimental Hematology,2010;38:677–684
14、Li X et al#. Diagnosis of unknown non- hematological tumors by bone marrow biopsy: a retrospective analysis of 10112 samples. J Cancer Res Oncol,2009;135:687-693
15、LINGYUN WU, XIAO LI#, JIYING SU,et al.. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome. . Leukemia Lymphoma,2009;50(9): 1461–1467
16、Li Xu, Chunkang Chang, Xiao Li#,et al.. Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield of CD341 Cells in autoPBSCT.. Journal of Clinical Apheresis,2009;24(6):232-237
17、Li Xiao#, Song Luxi, Tao Ying, et al.. Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. . J Cancer Res Clin Oncol,2009;135:687–693
18、Li Xu, Chunkang Chang, Xiao Li#,et al.. Appropriate Timing of G-CSF Use After Mobilization Chemotherapy Significantly Increases the Yield of CD34+ Cells in autoPBSCT.. Journal of Clinical Apheresis,2009;24(6):232-237
19、L. WU, X Li#, C Chang, et al.. Deviation of type I and type II T cells and its negative effect on hematopoiesis in myelodysplastic syndrome.. Int J Lab Hematol,2008;30(5):390-399
20、Li X#, Wu L, Ying S, et al.. Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows. . Int J Hematol,2008;87(2):176-83.
21、Li Xiao et al#. Differentiation and hematopoietic- support of clonal cells in myelo- dysplastic syndromes. Leukemia and Lymphoma,2007;48(7):1353-1371
22、Li Xiao et al#. Wilm’s tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes. Leukemia and Lymphoma,2007;48(3):601-604
|
